Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Focal Segmental Glomerulosclerosis. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
40 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for focal segmental glomerulosclerosis. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
36 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for focal segmental glomerulosclerosis. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(19 grants)
These grants mention Focal Segmental Glomerulosclerosis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(19)
OtherR01Active
Podocyte-specific Rap1 agonism for treatment of glomerular disease
Kaufman, Lewis·ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI·NEW YORK, NY
